TLT — Theralase Technologies Cashflow Statement
0.000.00%
Last trade - 00:00
- CA$37.93m
- CA$37.86m
- CA$1.14m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -3.36 | -7.41 | -5.6 | -4.41 | -5.24 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 0.187 | 0.422 | 0.93 | 0.342 | 0.241 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.73 | 0.17 | -0.05 | -0.238 | -0.452 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -1.22 | -6.57 | -4.45 | -4.03 | -5.13 |
Capital Expenditures | -0.134 | -0.533 | -0.165 | -0.101 | -0.07 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | — | — | — | — |
Sale of Fixed Assets | |||||
Cash from Investing Activities | -0.134 | -0.533 | -0.165 | -0.101 | -0.07 |
Financing Cash Flow Items | — | -1.6 | 0 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 2.13 | 18.6 | -0.058 | -0.057 | 3.02 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.78 | 11.5 | -4.67 | -4.19 | -2.18 |